Looking for prostate support? ProstaVive reviews shares how it improved energy and flow. Read real user reviews to see if ...

Trybello has released a new guide for men stopping dutasteride for hair loss. The resource details what to expect after ...

Thinning hair is one of those things almost every guy ends up worrying about. By the time some hit their mid-30s, about two-thirds of men notice some kind of hair loss – and let’s be real, for most it ...

Trybello has announced a new auto-delivery mechanism for their caffeine-enriched Bello Hair Helper Spray, improving application precision. The topical treatment increases scalp blood flow, aims to ...

To be clear, the best hair-growth shampoos are not miracle cures. Many experts are still divided on whether they can truly stop hair loss. What they can do is help maintain the healthiest possible ...

A meta-analysis showed no significant differences between JAK inhibitor use and TNF antagonist use in terms of the risk for serious infections or malignant neoplasms in patients with immune-mediated ...

Angiotensin converting enzyme (ACE) inhibitors, a type of blood pressure medication, are usually well tolerated, but one of their rare side effects is angioedema. Angiotensin converting enzyme (ACE) ...

Please provide your email address to receive an email when new articles are posted on . TL1A inhibitors have shown both anti-inflammatory and anti-fibrotic activity in IBD. This class of drugs offers ...

The MARIPOSA trial demonstrates that amivantamab plus lazertinib significantly reduces resistance and extends survival in EGFR-mutated NSCLC compared to osimertinib. Dual inhibition of EGFR and MET by ...

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Noticing a receding hairline? You’re not alone — and thanks to ...

Collaboration highlights Hengrui Pharma's successful use of the NewCo model to achieve another out-licensing deal Agreement grants Braveheart Bio exclusive global rights to develop, manufacture and ...

The FDA approved oral rilzabrutinib (Wayrilz) for treating persistent or chronic immune thrombocytopenia (ITP), the agency announced on Tuesday. As the first Bruton's tyrosine kinase (BTK) inhibitor ...